A pan-viral medicine could be an anticancer candidate that targets a human protein
Editor More than two years after the COVID-19 pandemic began, people are understanding that adapting to SARS-CoV-2 will likely…
More than two years after the COVID-19 pandemic began, people are understanding that adapting to SARS-CoV-2 will likely…
